Success Story: NIW Approved for MRI Researcher Enhancing Imaging Speed, Resolution, and Safety

Client’s Testimonial:

“Working with Chen Immigration was a smooth and professional experience. Their team clearly understood the value of my research and presented it effectively in the petition.

They were organized, responsive, and skilled at translating technical work into a strong case for national benefit. Thanks to their guidance, my NIW petition was approved under standard processing. I highly recommend NAILG to any researcher pursuing this path.”

On March 8^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Scientist (Approval Notice).

Position at the Time of Case Filing: Research Scientist

Country of Origin: Turkey

State of Residence at the Time of Filing: California

Approval Notice Date: March 8^th, 2025

Processing Time: 1 year, 4 months

Case Summary:

We are pleased to share the successful NIW approval for a researcher from Turkey specializing in medical imaging. His proposed endeavor focuses on advancing MRI technologies that improve scan speed, image resolution, and patient safety. As a postdoctoral researcher in electrical and electronics engineering, he is developing next-generation gradient coils and enabling faster, safer diagnostic imaging. His work has a direct impact on reducing healthcare costs, enhancing diagnostic accuracy, and supporting public health priorities in the U.S.

Enhancing MRI Technology for Public Health

These contributions are essential to improving diagnostic throughput in hospitals, reducing costs, and expanding access to high-quality imaging in underserved populations. With over 30 million MRI scans conducted in the U.S. annually, enhancements in imaging efficiency and safety offer a significant national benefit.

Research Impact and Professional Recognition

To support this petition, we submitted strong evidence of the client’s scientific impact and peer recognition:

● 12 scientific works, including 3 peer-reviewed journal articles (all first-authored), 9 cited abstracts, and 1 preprint.

● 89 citations across leading publications in magnetic resonance imaging.

● 5 patent contributions (4 granted and 1 pending), demonstrating his role in technology innovation.

● Reviewer for at least 9 peer-reviewed journals, including Magnetic Resonance in Medicine and Medical Physics.

His publications have been cited by researchers worldwide working on cutting-edge developments in MRI hardware design and patient safety, reflecting widespread reliance on his methods and findings.

National Benefit and Policy Alignment

Our legal team emphasized that the client’s research directly supports national goals related to critical and emerging technologies (CETs), particularly in health-sector sensing and advanced diagnostics. His work aligns with NIH priorities and addresses national healthcare demands by enabling safer, faster, and more accurate MRI scans. We highlighted that his efforts enhance the U.S. technological edge in healthcare infrastructure and diagnostic innovation.

Approval and Outcome

Filed in November 2023 and approved in March 2025, this case was successfully adjudicated under standard processing. The approval underscores the strength of the client’s qualifications, his contributions to U.S. science and technology leadership, and the importance of medical imaging research in public health.

We are proud to have supported this client’s petition and celebrate his well-earned success. NAILG remains committed to empowering innovators whose work strengthens healthcare, science, and technology in the United States.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.